MomentumTradingHQ.com Featured Stock for the Week of 12/29/25 - 1/2/26: Sellas Life Sciences (SLS) Day Trade Return of 16.3%

Sellas Life Sciences, a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, provided an update on the ongoing Phase 3 REGAL trial evaluating GPS as a potential maintenance therapy in patients with AML after second complete remission.

Our proprietary real time alert services picked up SLS's unusual stock and option volume Monday morning. Depending on your favorite momentum indicator several opportunities presented themselves to get in to capture a portion of the daily return.

As shown in the chart below, a day trade entered at 9:40 am and closed at the end of the day would have gained 16.3%. The chart shows the indicators that were triggered as well as the time.

If you are interested in getting real time stock alerts sent to your email visit MomentumTradingHQ.com and subscribe to the indicator alert service that fits your trading style. There is currently a 7 day free trial.

If you are interested in receiving the Featured Stock of the Week email and/or blog visit MomentumTradingHQ.com and sign up for free.